• Pawelec G, Schneider EM, Wernet P: Human T-cell clones with multiple and changing functions: indications of unexpected flexibility in immune response networks. Immunology Today 4:275, 1983
  • Eckels DD, Zeevi A, Beatty PG, Flomenberg N, Goyert S, Knowles RW, Mickelson E, Nepom GT, Parham P, Pawelec G, Reinsmoen N: ASHI Workshop summary report of the science and education subcommittee: structural and functional relationships of human class II MHC molecules. Human Immunology 15:68, 1986
  • Pawelec G, Adibzadeh M, Pohla H, Schaudt K: Immunosenescence: ageing of the immune system. Immunol Today 16:420, 1995
  • Pawelec G, Adibzadeh M, Solana R, Beckman I: The T cell in the ageing individual. Mech Ageing Dev 93:35, 1997
  • Pawelec G, Solana R: Immunosenescence. Immunol Today 18:514, 1997
  • Kipling D, Wynford-Thomas D, Jones CJ, Akbar A, Aspinall R, Bacchetti S, Blasco MA, Broccoli D, De Pinho RA, Edwards DR, Effros RB, Harley CB, Lansdorp PM, Linskens MHK, Prowse KR, Newbold RF, Olovnikov AM, Parkinson EK, Pawelec G, Ponten J, Shall S, Zijlmans M, Faragher RGA: Telomere- dependent senescence. Nature Biotech 17:313, 1999
  • Pawelec G, Adibzadeh M, Wagner W, Engel A. T cell immunosenescence in vitro and in vivo. Exp Gerontol 34:419, 1999
  • Pawelec G: Tumour escape from the immune response: the last great hurdle for successful immunotherapy of cancer? [Introduction to a "Symposium in Writing" edited by GP]. Cancer Immunol Immunother 48:343, 1999
  • Pawelec G: Prerequisites for the immunotherapy of cancer. Report of the Second EUCAPS Meeting, Blaubeuren, February, 1999. Cancer Immunol Immunother 48:214, 1999
  • Pawelec G: Immunosenescence: impact in the young as well as the old? Mech Ageing Dev 108:1, 1999
  • Pawelec G: Meeting report: First conference of the EU-supported Thematic Network on Immunology and Ageing in Europe (ImAginE), Schloß Hohentübingen, April 2000. Exp Gerontol 35: 1095, 2000
  • Pawelec G: Working Together for Robust Immune Responses in the Elderly. Nature Immunol 1:91, 2000
  • Pawelec G: New methods to approach immunotherapy of cancer - and strategies of tumours to avoid elimination. Conference report, on behalf of EUCAPS. Cancer Immunol immunother 49:276, 2000
  • Pawelec G: Hypothesis: Loss of telomerase inducibility and subsequent replicative senescence in cultured human T cells is a result of altered costimulation. Mech Ageing Dev 121: 181, 2000
  • Kiessling R, Pawelec G, Welsh R, Barry JD, Ferrone S: Have tumor cells learnt from microorganisms how to fool the immune system? Escape from immune surveillance of tumors and microorganisms: emerging mechanisms and shared strategies, Naples, Italy, 23-27 March 2000. Mol Med Today 6:344, 2000